In 2023, France led the global export of insulin in dosage forms, commanding 30.93% of the market share by kilogram, followed by India at 20.5% and Italy at 11.81%. Significant year-on-year increases were observed in Slovenia (170.58%), Chile (77.58%), and El Salvador (56.77%), while Brazil and Morocco experienced declines of 7.39% and 4.61%, respectively. Over a five-year period, the compound annual growth rate (CAGR) for many countries suggests moderate growth, with rapidly burgeoning markets such as Slovenia and Estonian emerging prominently.
Future trends in global insulin exports will likely focus on:
- Increasing production capacity in developing countries like India and China.
- Expansion of insulin production in smaller export markets, such as Slovenia and Chile.
- The potential impact of technological advancements and biosimilar insulin developments on traditional markets.
- Monitoring the regulatory landscape, which may influence export dynamics.
Top countries in Export of Insulin in Dosage Forms Share by Country (Kilograms)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 France | 30.93 | 2023 | +1.98% | +4.01% | View data |
| 2 | 2 India | 20.5 | 2023 | +1.65% | +4.11% | View data |
| 3 | 3 Italy | 11.81 | 2023 | +4.07% | +5.89% | View data |
| 4 | 4 Germany | 10.81 | 2023 | +2.57% | +3.06% | View data |
| 5 | 5 United States | 9.43 | 2023 | +0.73% | +1.73% | View data |
| 6 | 6 China | 4.15 | 2023 | +5.43% | +5.18% | View data |
| 7 | 7 Brazil | 2.87 | 2023 | -10.23% | -7.39% | View data |
| 8 | 8 Hungary | 1.78 | 2023 | +2.09% | +1.49% | View data |
| 9 | 9 Belgium | 1.51 | 2023 | +4.65% | +4.77% | View data |
| 10 | 10 United Kingdom | 1.17 | 2023 | +3.19% | +3.34% | View data |
